Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,130 | 1,891 | 99.3% |
| Education | $213.26 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,320 | 245 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,990 | 91 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,180 | 136 | $0 (2024) |
| Gilead Sciences, Inc. | $2,116 | 123 | $0 (2024) |
| ABBVIE INC. | $1,999 | 118 | $0 (2024) |
| Novo Nordisk Inc | $1,829 | 148 | $0 (2024) |
| Lilly USA, LLC | $1,768 | 150 | $0 (2024) |
| Antares Pharma, Inc. | $1,761 | 164 | $0 (2024) |
| Amarin Pharma Inc. | $1,287 | 66 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $976.39 | 63 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,855 | 236 | Antares Pharma, Inc. ($428.50) |
| 2023 | $3,871 | 231 | AbbVie Inc. ($575.26) |
| 2022 | $3,103 | 187 | ABBVIE INC. ($455.93) |
| 2021 | $4,358 | 268 | Amgen Inc. ($691.46) |
| 2020 | $3,593 | 236 | Amgen Inc. ($627.15) |
| 2019 | $3,867 | 248 | Amgen Inc. ($682.94) |
| 2018 | $3,818 | 219 | Amgen Inc. ($711.94) |
| 2017 | $3,878 | 274 | Novo Nordisk Inc ($635.06) |
All Payment Transactions
1,899 individual payment records from CMS Open Payments — Page 1 of 76
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.82 | General |
| 12/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.90 | General |
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $5.92 | General |
| 12/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.26 | General |
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Obesity | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,160 | 4,735 | $488,623 | $132,196 |
| 2022 | 26 | 2,123 | 4,532 | $437,195 | $114,673 |
| 2021 | 29 | 2,119 | 4,314 | $372,356 | $105,615 |
| 2020 | 18 | 762 | 1,881 | $218,563 | $60,235 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 466 | $121,200 | $25,735 | 21.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 101 | 507 | $63,375 | $22,104 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 184 | $64,150 | $15,772 | 24.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 93 | 351 | $36,855 | $11,322 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $20,864 | $8,063 | 38.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 103 | 172 | $18,576 | $4,350 | 23.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 125 | 256 | $17,920 | $4,214 | 23.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 125 | 239 | $11,950 | $3,967 | 33.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 40 | $10,400 | $3,790 | 36.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 127 | 265 | $14,840 | $3,477 | 23.4% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 63 | $8,190 | $3,248 | 39.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 132 | 292 | $12,848 | $3,022 | 23.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 111 | 187 | $11,781 | $2,764 | 23.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $5,700 | $2,733 | 48.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 136 | 309 | $6,245 | $2,596 | 41.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 133 | 288 | $7,913 | $2,192 | 27.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 125 | 241 | $8,917 | $2,130 | 23.9% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 49 | 70 | $7,770 | $1,917 | 24.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 195 | $14,281 | $1,696 | 11.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $1,855 | $1,504 | 81.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 52 | 52 | $2,704 | $904.28 | 33.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 90 | $3,690 | $856.80 | 23.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 38 | 46 | $3,542 | $828.92 | 23.4% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2023 | 31 | 43 | $3,354 | $783.03 | 23.3% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 13 | 14 | $2,800 | $573.58 | 20.5% |
About Dr. David Sharp, D.O
Dr. David Sharp, D.O is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932117470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sharp, D.O has received a total of $30,343 in payments from pharmaceutical and medical device companies, with $3,855 received in 2024. These payments were reported across 1,899 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($30,130).
As a Medicare-enrolled provider, Sharp has provided services to 7,164 Medicare beneficiaries, totaling 15,462 services with total Medicare billing of $412,718. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Omaha, NE
- Active Since 08/03/2006
- Last Updated 11/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932117470
Products in Payments
- ENTRESTO (Drug) $1,645
- Vascepa (Drug) $1,287
- EVENITY (Biological) $1,059
- UBRELVY (Drug) $981.73
- Aimovig (Biological) $972.56
- XYOSTED (Drug) $964.86
- Otezla (Drug) $853.23
- FARXIGA (Drug) $808.52
- Ozempic (Drug) $746.46
- XARELTO (Drug) $746.16
- Prolia (Biological) $655.83
- SYMBICORT (Drug) $653.51
- NURTEC ODT (Drug) $649.99
- Repatha (Biological) $605.34
- VRAYLAR (Drug) $563.43
- LEQVIO (Drug) $535.42
- QULIPTA (Drug) $483.57
- EMGALITY (Drug) $459.57
- Victoza (Drug) $458.18
- TRULICITY (Drug) $450.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335